Preoperative chemoradiation with capecitabine and cetuximab within a multidisciplinary therapeutic approach in patients with operable T4 rectal cancer: a phase II study.

Trial Profile

Preoperative chemoradiation with capecitabine and cetuximab within a multidisciplinary therapeutic approach in patients with operable T4 rectal cancer: a phase II study.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2015

At a glance

  • Drugs Capecitabine; Cetuximab
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Dec 2015 New source identified and integrated as European Clinical Trials Database (EudraCT2005-003740-62).
    • 29 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top